In 2004, Li and co-workers isolated descurainin (1) from the seeds of Descurainia sophia (L.) Webb ex Prantl, which are widely used as Chinese traditional medicine to relieve coughing, prevent asthma, reduce edema and promote urination. 1 Compound 2 2 and cartorimine (3), 3 possessing an 8oxabicylo[3.2.1]oct-3-en-2-one ring system, were isolated from Ligusticum chuanxing Hort. and Carthamus tinctorius L. by the Wen and He groups, respectively. Snider and Grabowski reported a concise total synthesis of (±)-1-3, in which the fully functionalized 8-oxabicyclo[3.2.1]octenone skeleton was efficiently constructed by a possible biomimetic [5+2] cycloaddition of oxidopyrylium ion. 4  The dirhodium(II) complex-catalyzed tandem cyclic carbonyl ylide formation-1,3-dipolar cycloaddition reaction sequence represents one of the most powerful methods for the rapid assembly of complex oxapolycyclic systems. 5-8 An ---(S. Hashimoto). enantioselective version of this sequence catalyzed by chiral dirhodium(II) complexes has also been developed. 9-12 Recently, we reported an enantioselective 1,3-dipolar cycloaddition of a six-membered cyclic formyl-carbonyl ylide with phenylacetylene derivatives using dirhodium(II) tetrakis[N-tetrachlorophthaloyl-(S)-tert-leucinate], Rh 2 (S-TCPTTL) 4 (4), 13-15 as a catalyst. 16 The reaction between tert-butyl 2-diazo-5-formyl-3-oxopetanoate (6) and 4-hydroxy-3-methoxyphenylacetylene (7) provided 8oxabicyclo[3.2.1]octane derivative 8 in 73% yield with 95% ee (Eq. 1). Using this catalytic methodology, we achieved the first asymmetric synthesis of ent-2. 16 The absolute maximal molar circular dichroism of synthetic material ent-2 ( −3.81 at 348 nm) displayed a startling difference in magnitude to that of natural product 2 (+0.
suggested that natural product 2 might be biosynthesized in nearracemic form like polygalolides A and B. 17, 18 Our results provided experimental support for the biogenetic hypothesis by Snider's group. 4b As an extension of our study in this field, we herein report an asymmetric synthesis of descurainin (1) using the carbonyl ylide cycloaddition methodology.
Our synthetic strategy is outlined retrosynthetically in Scheme 1. We envisaged that 1 would be accessible from -ketoester 9, which would be derived from bicyclic compound 10 in a stereocontrolled manner. On the basis of our previous work, 16 we envisioned that the cycloaddition of a carbonyl ylide derived from -diazo--ketoester 6 with phenylacetylene derivative 11 using Rh 2 (R-TCPTTL) 4 (5) 19 would provide cycloadduct 10.
Toward this end, we initially examined the reaction of diazo--ketoester 6 16 with a variety of 3,5-dimethoxy-4hydroxyphenylacetylene derivatives 11a-d in the presence of 1 mol % of Rh 2 (R-TCPTTL) 4 (5) in ,,-trifluorotoluene at room temperature ( Table 1 , entries 1-4). The reaction of 6 with phenylacetylene 11a bearing a free phenolic hydroxy group gave cycloadduct 12a in 55% yield (entry 1). The enantiomeric excess of 12a was determined to be 50% by HPLC using a Chiralcel OD-H column. Switching the dipolarophile to tertbutyldimethylsilyl (TBS)-or methyl-protected phenylacetylenes Scheme 1. Retrosynthetic analysis of descurainin (1). 11b and 11c resulted in a noticeable drop in both product yields (39% and 44%, respectively) and enantioselectivities (26% ee and 20% ee, respectively) compared to those with 11a (entries 2 and 3). The use of acetyl-protected phenylacetylene 11d caused a sharp drop in enantioselectivity, though cycloadduct 12d was obtained in good yield (62% yield, 1% ee, entry 4). It is noteworthy that the steric and electronic nature of dipolarophiles markedly influenced both product yield and enantioselectivity. 10b,c These unsatisfactory results led us to change our strategy. We envisioned that the enantiomer of bicyclic compound 8 possessing a 4'-hydroxy-3'-methoxybenzene ring would be an intermediate for the synthesis of 1 via installation of a methoxy group at the C5' position on the aromatic ring. Thus, the reaction of 6 with 4-hydroxy-3methoxyphenylacetylene (7) as a dipolarophile in the presence of Rh 2 (R-TCPTTL) 4 (5) was performed to provide the desired cycloadduct ent-8, [] D 22 −148.5 (c 1.09, CHCl 3 ), in 77% yield with virtually the same enantioselectivity (95% ee) as those found in our previous study (entry 5). 16, 20 Catalytic hydrogenation of ent-8 provided exclusively the desired endo-bicyclic compound 13 as a single diastereomer in 99% yield (Scheme 2). 21 We then investigated installation of a hydroxy group at the C5' position on the aromatic ring via formation of o-quinone. Treatment of phenol 13 with (KSO 3 ) 2 NO (Fremy's salt) 22 in the presence of KH 2 PO 4 gave o-quinone 14.
Keeping the reaction time short prevented significant loss of product yield. The resultant o-quinone 14 was immediately converted into catechol 15 by treatment with Na 2 S 2 O 4 in 73% yield in two steps from 13. 23 Since attempts at regioselective methylation of 15 were unsuccessful, 24 we turned our attention to the viability of a regioselective demethylation of trimethoxybenzene derivative. Treatment of 15 with MeI (4 equiv.) and K 2 CO 3 afforded per-methylated product 16 in quantitative yield.
With an efficient installation of a methoxy group at the C5' position realized, the stage was now set for completion of the asymmetric synthesis of 1 as illustrated in Scheme 3. Treatment of ketone 16 with NaHMDS at −78 °C followed by addition of PhNTf 2 and subsequent palladium-catalyzed reduction of the resulting enol triflate 25 furnished alkene 17 in 81% yield. Reduction of 17 with LiAlH 4 provided alcohol 18 in quantitative yield. Next, regioselective demethylation of 18 was investigated under a variety of conditions. This transformation turned out to be even more difficult than we anticipated, as the bicyclic component was prone to decomposition under acidic conditions (HBr, TMSI, MeSO 3 H/NaI or BF 3 •OEt 2 /NaI) frequently used in Scheme 2. Reagents and conditions: (a) H2, 10% Pd/C, MeOH, 1 h, 99%; (b) (KSO3)2NO, KH2PO4, acetone/H2O (3:1), 10 min; (c) Na2S2O4, KH2PO4, EtOAc/H2O (5:1), 0.5 h, 73% (two steps); (d) In summary, we have achieved the first catalytic asymmetric synthesis of descurainin. The key features of this synthesis include an efficient construction of the 8-oxabicyclo[3.2.1]octane skeleton employing Rh 2 (R-TCPTTL) 4 -catalyzed tandem formylderived carbonyl ylide formation-1,3-dipolar cycloaddition, a stereoselective alkene hydrogenation, an oxidation with Fremy's salt and a regioselective demethylation with NbCl 5 developed by the group of Arai and Nishida. Further application of the catalytic enantioselective carbonyl ylide cycloaddition methodology to asymmetric synthesis of biologically active natural products is currently in progress. 
